Mycobacterium bovis bacillus Calmette-Guérin infection promotes SOCS induction and inhibits IFN-γ-stimulated JAK/STAT signaling in J774 macrophages

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 2, 2003, Pages 173-180

  Imai, Kenichi ^a,c   Kurita Ochiai, Tomoko ^b   Ochiai, Kuniyasu ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Interferon ; Mycobacterial infection; Signal transducer and activation of transcription; Suppressor of cytokine signal

Indexed keywords

BINDING PROTEIN; CORD FACTOR; CYTOKINE; GAMMA INTERFERON; JANUS KINASE; MESSENGER RNA; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNAL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INACTIVATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MOLECULAR DYNAMICS; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUPPRESSOR GENE; TRANSCRIPTION INITIATION;

EID: 0242391852     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00231-1     Document Type: Article

References (47)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J. Am. Med. Assoc. 282:1999;677-686.
2. Russell D.G. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2:2001;569-577.
3. Pollock J.M., McNair J., Welsh M.D., Girvin R.M., Kennedy H.E., Mackie D.P., Neill S.D. Immune responses in bovine tuberculosis. Tuberculosis (Edinb.). 81:2001;103-107.
4. Pollock J.M., Neill S.D. Mycobacterium bovis infection and tuberculosis in cattle. Vet. J. 163:2002;115-127.
5. Wedlock D.N., Skinner M.A., de Lisle G.W., Buddle B.M. Control of Mycobacterium bovis infections and the risk to human populations. Microbes Infect. 4:2002;471-480.
6. Albrecht H., Stellbrink H.J., Eggers C., Rusch-Gerdes S., Greten H. A case of disseminated Mycobacterium bovis infection in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 14:1995;226-229.
7. Bouvet E., Casalino E., Mendoza-Sassi G., Lariven S., Vallee E., Pernet M., Gottot S., Vachon F. A nosocomial outbreak of multidrug-resistant Mycobacterium bovis among HIV-infected patients. A case-control study. Aids. 7:1993;1453-1460.
8. Flynn J.L., Chan J. Tuberculosis: latency and reactivation. Infect. Immun. 69:2001;4195-4201.
9. McCarthy M. Tuberculosis experts review 10 years of progress. Lancet Infect. Dis. 2:2002;387.
10. Frehel C., de Chastellier C., Offredo C., Berche P. Intramacrophage growth of Mycobacterium avium during infection of mice. Infect. Immun. 59:1991;2207-2214.
11. McDonough K.A., Kress Y., Bloom B.R. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect. Immun. 61:1993;2763-2773.
12. Reiner N.E. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today. 15:1994;374-381.
13. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:1983;670-689.
14. Nathan C.F., Prendergast T.J., Wiebe M.E., Stanley E.R., Platzer E., Remold H.G., Welte K., Rubin B.Y., Murray H.W. Activation of human macrophages. Comparison of other cytokines with interferon-γ J. Exp. Med. 160:1984;600-605.
15. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme I.M. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 178:1993;2243-2247.
16. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:1993;2249-2254.
17. Hmama Z., Gabathuler R., Jefferies W.A., de Jong G., Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161:1998;4882-4893.
18. Hussain S., Zwilling B.S., Lafuse W.P. Mycobacterium avium infection of mouse macrophages inhibits IFN-γ Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-γ receptor. J. Immunol. 163:1999;2041-2048.
19. Wojciechowski W., DeSanctis J., Skamene E., Radzioch D. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guerin involves class II transactivator and depends on the Nramp1 gene. J. Immunol. 163:1999;2688-2696.
20. Ting L.M., Kim A.C., Cattamanchi A., Ernst J.D. Mycobacterium tuberculosis inhibits IFN-γ transcriptional responses without inhibiting activation of STAT1. J. Immunol. 163:1999;3898-3906.
21. Douvas G.S., Looker D.L., Vatter A.E., Crowle A.J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun. 50:1985;1-8.
22. Rook G.A., Steele J., Ainsworth M., Champion B.R. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant γ-interferon on human monocytes and murine peritoneal macrophages. Immunology. 59:1986;333-338.
23. Darnell J.E. Jr., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
24. Ihle J.N. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60:1995;1-35.
25. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
26. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
27. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
28. Alexander W.S., Starr R., Fenner J.E., Scott C.L., Handman E., Sprigg N.S., Corbin J.E., Cornish A.L., Darwiche R., Owczarek C.M., Kay T.W., Nicola N.A., Hertzog P.J., Metcalf D., Hilton D.J. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell. 98:1999;597-608.
29. Song M.M., Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:1998;35056-35062.
30. Sakamoto H., Yasukawa H., Masuhara M., Tanimura S., Sasaki A., Yuge K., Ohtsubo M., Ohtsuka A., Fujita T., Ohta T., Furukawa Y., Iwase S., Yamada H., Yoshimura A. A Janus kinase inhibitor, JAB, is an interferon-γ-inducible gene and confers resistance to interferons. Blood. 92:1998;1668-1676.
31. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
32. Imai K., Takeshita A., Hanazawa S. Transforming growth factor-β inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression. Infect. Immun. 68:2000;2418-2423.
33. Takeshita A., Imai K., Kato S., Kitano S., Hanazawa S. 1α,25-Dehydroxyvitamin D3 synergism toward transforming growth factor-β1-induced AP-1 transcriptional activity in mouse osteoblastic cells via its nuclear receptor. J. Biol. Chem. 273:1998;14738-14744.
34. Byrd T.F., Horwitz M.A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83:1989;1457-1465.
35. Murray H.W., Granger A.M., Teitelbaum R.F. Gamma interferon-activated human macrophages and Toxoplasma gondii, Chlamydia psittaci, and Leishmania donovani: antimicrobial role of limiting intracellular iron. Infect. Immun. 59:1991;4684-4686.
36. Retzinger G.S., Meredith S.C., Hunter R.L., Takayama K., Kezdy F.J. Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6′-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6′-dimycolate monolayers. J. Immunol. 129:1982;735-744.
37. Spargo B.J., Crowe L.M., Ioneda T., Beaman B.L., Crowe J.H. Cord factor (alpha,alpha-trehalose 6,6′-dimycolate) inhibits fusion between phospholipid vesicles. Proc. Natl. Acad. Sci. USA. 88:1991;737-740.
38. Yamagami H., Matsumoto T., Fujiwara N., Arakawa T., Kaneda K., Yano I., Kobayashi K. Trehalose 6,6′-dimycolate (cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice. Infect. Immun. 69:2001;810-815.
39. Stoiber D., Kovarik P., Cohney S., Johnston J.A., Steinlein P., Decker T. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-γ J. Immunol. 163:1999;2640-2647.
40. Bode J.G., Nimmesgern A., Schmitz J., Schaper F., Schmitt M., Frisch W., Haussinger D., Heinrich P.C., Graeve L. LPS and TNFα induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages. FEBS Lett. 463:1999;365-370.
41. Stoiber D., Stockinger S., Steinlein P., Kovarik J., Decker T. Listeria monocytogenes modulates macrophage cytokine responses through STAT serine phosphorylation and the induction of suppressor of cytokine signaling 3. J. Immunol. 166:2001;466-472.
42. Dalpke A.H., Opper S., Zimmermann S., Heeg K. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166:2001;7082-7089.
43. Zhang Y., Broser M., Rom W.N. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB. Proc. Natl. Acad. Sci. USA. 91:1994;2225-2229.
44. Reiling N., Blumenthal A., Flad H.D., Ernst M., Ehlers S. Mycobacteria-induced TNF-α and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167:2001;3339-3345.
45. Chan E.D., Morris K.R., Belisle J.T., Hill P., Remigio L.K., Brennan P.J., Riches D.W. Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-κB signaling pathways. Infect. Immun. 69:2001;2001-2010.
46. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA. 96:1999;14459-14463.
47. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., Maitland M., Norgard M.V., Plevy S.E., Smale S.T., Brennan P.J., Bloom B.R., Godowski P.J., Modlin R.L. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science. 285:1999;732-736.